Animatus Biosciences

Regenerative medicine redefined

 
 
 
 
 
 
 

Animatus
Biosciences

Regenerative
medicine redefined

 
 
 
 

Heart failure is the single leading cause of morbidity and mortality in the developed world.

Treatment costs exceed $60 billion per year in the US alone.

The problem

There is currently no effective treatment that can reverse the course of heart failure because heart cells undergo
slow death over time and are unable
to replicate.

The problem

There is currently no effective treatment that can reverse the course of heart failure because heart cells undergo slow death over time and are unable to replicate

WHF Report 2020

23 Million

There are estimated to be 23 million chronic heart failure patients in the world.

CDC 2024

31%

The average mortality of these chronic heart failure patients is approximately 31%
per year.

OPTN 2023

10,121

The number of heart transplants performed worldwide 2023. Less than .5% of the 23 million chronic heart failure patients.

The Solution

Our scientists have developed a regenerative cocktail of synthetic factors that cause heart cells to replicate.

The Solution

Our scientists have developed a regenerative cocktail of synthetic factors that cause heart cells to replicate.

Interested in the next stage of regenerative medicine?

Interested in the next stage of regenerative medicine?